The Company
Flagship Labs 97, Inc. (FL97) is privately held, early-stage biotechnology pioneering the application of autonomous science to biology. At FL97 we recognize the potential for artificial intelligence to transform all aspects of the scientific method. FL97 is backed by Flagship Pioneering, which brings the courage, long-term vision, and resources needed to realize unreasonable results.
The Role
FL97 is seeking an experienced, creative, and talented Senior Scientist or Principal Scientist, Cellular Biology to join our team. You will be part of an agile, cross-functional team responsible for building the autonomous mammalian cell culture platform and executing closed-loop product discovery campaigns. Together with biologists, machine learning scientists, software developers, and automation engineers, you will work toward building and automating AI-driven stem cell biology and differentiation processes across a variety of valuable applications. All scientists must be willing to learn and use basic Python and/or R programming.
The ideal candidate brings primary expertise in stem cell biology, mammalian cell culture, and genetic engineering, with a proven track record of building high quality in vivo assay platforms. Industry experience in cell therapy, iPSCs, and/or regenerative medicine is highly desired.
Candidates should have experience and interest in:
- Cutting edge stem cell engineering approaches, techniques, and applications
- Mammalian gene editing technology (KO, targeted KI)
- Nonviral payload delivery using electroporation, PiggyBAC, or other relevant systems
- Radically new working styles and scientific approaches
- Learning to code experimental protocols and data analysis workflows in Python
In this role, you would:
- Work in a small, diverse, project-based team
- Flexibly react to new information within an agile framework
- Build novel, robust, working prototypes of engineered biological products
- Collaborate with machine learning, software, and automation experts
- Provide hands-on training to Research Associates and computational colleagues
- Actively shape and plan new projects at regular intervals
Working at FL97, you would have access to advanced technology in the areas of:
- AI experimental design and simulation
- Automated liquid handling and cell culture
- Fully digital lab workflows
Location: Cambridge, MA
More About Flagship Pioneering
Flagship Pioneering conceives, creates, resources, and develops first-in-category life science platform companies to transform human health and sustainability. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $100 billion in aggregate value. To date, Flagship has deployed over $3.1 billion in capital toward the founding and growth of its pioneering companies alongside more than $19 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises transformative companies, including Moderna (NASDAQ: MRNA), Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics (NASDAQ: MCRB), Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Foghorn Therapeutics (NASDAQ: FHTX), Indigo Ag, Generate Biomedicines, Tessera Tx, and others.
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.